SimplyShowMeTheMoney

$FB enter the metaverse

Long
NASDAQ:META   Meta Platforms
*This is not financial advice, so trade at your own risks*

*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*

*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*

Today my team will dive into Meta Platforms $FB formally known as Facebook. Its stock price began declining September 14, 2021 when the company experienced scrutiny concerning unethical practices. Another company that has received similar treatment in the past is Google $GOOGL...they are now at all-time highs.

$FB recently began what looks to be a reversal on October 28, 2021 when the company announced a change in their name from Facebook to Meta Platforms. They stated “Our company’s vision is to help bring the metaverse to life, so we are changing our name to reflect our commitment to this future.” Price has since increased from $308.11 to $345.30.

My team holds no positions currently, but we plan to begin accumulating shares tomorrow morning. $FB share price may experience a temporary boost due to hype before earnings. If this occurs, my team will more than likely sell our shares before the release of earnings. Our reason behind this is that we think $FB earnings will not reflect a hyped up share price. The metaverse still needs time to mature before $FB can see any substantial growth from it.

Earnings are expected to be released January 23, 2022, but this date is subject to change.

Entry point: $345
Take profit 1: $420
Take profit 2: $460


If you want to see more, please like and follow us @SimplyShowMeTheMoney
Comment:
We suggest that traders looking to get into $FB accumulate shares slowly. Share price may revisit $330.
Comment:
On November 26, 2021 my team purchased additional $FB at $335.50 per share.
Trade closed manually:
12/7/21
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.